Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ARG1 | P05089 | 1/20 | 0.39 |
| ▸ | DPP4 | P27487 | 4/20 | 0.33 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.31 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.31 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.31 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.31 |
| ▸ | SLC1A3 | P43003 | 1/20 | 0.31 |
| ▸ | SLC1A2 | P43004 | 1/20 | 0.31 |
| ▸ | SLC1A1 | P43005 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25366838 | 0.85 | ARG1 (0.54) | ARG1CYP1A2CYP2D6ALOX15CYP2C19 | |
| SCHEMBL17715175 | 0.85 | ARG1 (0.54) | ARG1CYP1A2CYP2D6ALOX15CYP2C19 | |
| SCHEMBL14979660 | 0.85 | ARG1 (0.54) | ARG1CYP1A2CYP2D6ALOX15CYP2C19 | |
| SCHEMBL6122490 | 0.85 | ARG1 (0.54) | ARG1CYP1A2CYP2D6ALOX15CYP2C19 | |
| SCHEMBL26116484 | 0.85 | ARG1 (0.54) | ARG1CYP1A2CYP2D6ALOX15CYP2C19 | |
| Hydrochloric Acid SCHEMBL29035430 | 0.83 | ARG1 (0.53) | ARG1CYP1A2CYP2D6ALOX15CYP2C19 | |
| Hydrochloric Acid SCHEMBL25361652 | 0.83 | ARG1 (0.53) | ARG1CYP1A2CYP2D6ALOX15CYP2C19 | |
| SCHEMBL30571958 | 0.83 | CHRNB2 (0.39) | ARG1DPP4CYP1A2CYP2D6ALOX15 | |
| Hydrochloric Acid SCHEMBL25362592 | 0.83 | ARG1 (0.53) | ARG1CYP1A2CYP2D6ALOX15CYP2C19 | |
| SCHEMBL14979674 | 0.83 | CHRNB2 (0.39) | ARG1DPP4CYP1A2CYP2D6ALOX15 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10766912-B2 | Silicon-containing compound for resistance to hepatitis C virus infection | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD. (CN) | 2020-09-08 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10766912-B2 | Silicon-containing compound for resistance to hepatitis C virus infection | SLC11A2, SLC10A1, SLC39A11 | ARG1 2638/4885DPP4 823/4885CYP1A2 2432/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.